claim: India’s first indigenous Covid-19 vaccine Covaxin, codenamed BBV152, is safe, immunogenic and has no serious adverse effects, medical journal Lancet has said while publishing the vaccine’s phase 2 trial results #COVID19 #COVID19Vaccine #Covaxin https://t.co/ul137quDJz